What makes a good RP?
What makes a good RP? – The Responsible Person (RP) title is the named person on a Wholesale Distribution Authorisation (WDA).
Hub and spoke dispensing consultation
On 16th March 2022, the Department of Health and Social Care launched its long-anticipated open consultation and consultation document into whether the law should be changed to allow community pharmacies to use ‘Hub & Spoke’ dispensing business models.
Clover the Medicinal Benefits, Not just a Lucky Charm
When Saint Patrick was Christianising Ireland in the 5th Century, the Shamrock (or four-leaf clover) was used by him to illustrate the Holy Trinity doctrine to the population. St Patrick is the patron saint of Ireland, and the four-leaf clover has been used as its symbol since the 18th Century.
GPhC Standards app closure
The regulatory body for pharmacists, pharmacy technicians, and pharmacies in Great Britain will be discontinuing their ‘GPhC Standards App’ on 20th March 2022.
Confirming the Licensed Status of a Medicine
Unlicensed Medicines (Specials) can only be supplied under one of the following circumstances:
Celebrating Women In Pharmacy History
Historically, women have always had a substantial role to play in pharmacy, however, when the Royal Pharmaceutical Society was founded in Great Britain on 15th April 1841.
We are ‘Back in the Room’
As part of our covid risk assessment and the lifting of the restrictions in the UK we are delighted to be able to once again offer our popular ‘Face to Face’ ‘Cogent Gold Standard Responsible Person Training Course’.
Unlicensed Specials
Unlicensed Specials – Medicines made by manufacturers under a “Specials” licence.
Prescribing and Dispensing
Prescribing and Dispensing – Rural GP practices can act as Dispensing Doctors which means they can perform both the Prescribing and Dispensing of medication if it would be difficult for their patients to access a local pharmacy.
Advanced Therapy Medicinal Products (ATMPs)
Advanced Therapy Medicinal Products (ATMPs) are medicines based on genes, tissues or cells for human use. ATMPs offer an innovative perspective for the treatment of disease and injury.